Matisse Capital ASND Holdings History
Matisse Capital's Ascendis Pharma AS Holding Summary
As of 2025-06-30, Matisse Capital held 27,942.00 shares of Ascendis Pharma AS(ASND), totaling $4.82 Mil. This investment constitutes 2.28% of their stock portfolio, and Matisse Capital now holds 0.05% of the outstanding Ascendis Pharma AS(ASND) stock.
The initial trade took place in 2018Q2. And since then Matisse Capital has made 17 purchases of ASND, at an average price of $116.98, for a total of 103,085.00 shares. In addition, there have been 11 sales at an average price of $115.84 for 75,143.00 shares. Based on historical transaction data and ASND's current price of $170.14, Matisse Capital's estimated gain on his ASND holdings is $1.40 Mil, reflecting a 11.61% gain to date.
Matisse Capital ASND ($170.14) Holding Chart
Matisse Capital ASND ($170.14) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
